Anecortave Acetate Versus Placebo in AMD Patients Following PDT
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy of anecortave acetate for depot
suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual
acuity in patients with wet AMD.